
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery
Sponsor : Ginkgo Bioworks
Deal Size : Undisclosed
Deal Type : Acquisition
Ginkgo Bioworks Acquires Modulus Cell Therapy Platform Assets
Details : Through the acquisition, Ginkgo will get access to the Modulus cell therapy platform assets, including their chimeric antigen receptor and switch receptor libraries for solid tumors, autoimmune, etc.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 02, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery
Sponsor : Ginkgo Bioworks
Deal Size : Undisclosed
Deal Type : Acquisition
